scispace - formally typeset
E

Elizabeth W. Pugh

Researcher at Johns Hopkins University School of Medicine

Publications -  37
Citations -  6573

Elizabeth W. Pugh is an academic researcher from Johns Hopkins University School of Medicine. The author has contributed to research in topics: Genome-wide association study & Single-nucleotide polymorphism. The author has an hindex of 25, co-authored 37 publications receiving 5875 citations. Previous affiliations of Elizabeth W. Pugh include National Institutes of Health & Johns Hopkins University.

Papers
More filters
Journal ArticleDOI

Association analysis identifies 65 new breast cancer risk loci

Kyriaki Michailidou, +396 more
- 02 Nov 2017 - 
TL;DR: A genome-wide association study of breast cancer in 122,977 cases and 105,974 controls of European ancestry and 14,068 cases and 13,104 controls of East Asian ancestry finds that heritability of Breast cancer due to all single-nucleotide polymorphisms in regulatory features was 2–5-fold enriched relative to the genome- wide average.
Journal ArticleDOI

Genomewide association study for susceptibility genes contributing to familial Parkinson disease.

TL;DR: The first genomewide association study in familial Parkinson disease has performed, suggesting the identification of new susceptibility alleles for PD in the GAK/DGKQ region, and providing further support for the role of SNCA and MAPT in PD susceptibility.
Journal ArticleDOI

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

Catherine M. Phelan, +443 more
- 01 May 2017 - 
TL;DR: Integrated analyses of genes and regulatory biofeatures at each locus predicted candidate susceptibility genes, including OBFC1, a new candidate susceptibility gene for low-grade and borderline serous EOC.
Journal ArticleDOI

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

Roger L. Milne, +512 more
- 23 Oct 2017 - 
TL;DR: A genome-wide association study (GWAS) of predominantly estrogen receptor (ER)-positive disease and BRCA1 mutation carrier GWAS observed consistent associations with ER-negative disease for 105 susceptibility variants identified by other studies, which explain approximately 16% of the familial risk of this breast cancer subtype.